Health News
FDA: Chantix (varenicline) May Increase Cardiovascular Risk
The U.S. Food and Drug Administration (FDA) is notifying the public that the smoking cessation aid Chantix ( varenicline ) may be associated with a small, increased risk of certain cardiovascular adverse events in patients who have cardiovascular disease.
Second-Hand Smoke Does It Again
Past studies have shown that women smokers have a higher risk of cervical cancer. Now, new research shows that second-hand smoke may damage cells in a woman's cervix, increasing her risk of cervical cancer.